The Number of LDL Particles: The Hidden Metric That Explains True Atherosclerotic Risk in Dyslipidemia
LDL-C as a Traditional Therapeutic Target Historically, LDL-C has been maintained as the primary therapeutic target in the prevention of atherosclerotic cardiovascular disease (ASCVD), with the goal of reducing its plasma concentration as much as possible. However, the prevalence of residual risk—even in patients with LDL-C levels within the optimal range—has compelled the scientific community […]